Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Callisia N. Clarke MD

Callisia N. Clarke MD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Surgery
Division: Surgical Oncology

Member of the Cancer Center


  • Elective Regional Therapy Treatment for Hepatic Adenoma. (Silva JP, Klooster B, Tsai S, Christians KK, Clarke CN, Mogal H, Clark Gamblin T) Ann Surg Oncol 2019 Jan;26(1):125-130 PMID: 30353390 10/26/2018    
  • Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages. (Silva-Figueroa A, Villalobos P, Williams MD, Bassett RL Jr, Clarke CN, Lee JE, Busaidy NL, Perrier ND) Surgery 2018 Nov;164(5):960-964 PMID: 30033186 07/24/2018    
  • The effect of prior upper abdominal surgery on outcomes after liver transplantation for hepatocellular carcinoma: An analysis of the database of the organ procurement transplant network. (Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC) Surgery 2018 05;163(5):1028-1034 PMID: 29398041 02/06/2018    
  • Arginine methylation of EGFR: a new biomarker for predicting resistance to anti-EGFR treatment. (Korphaisarn K, Chou CK, Xia WY, Clarke CN, Katkhuda R, Davis JS, Raghav KP, Liao HW, Wu JY, Menter DG, Maru DM, Hung MC, Kopetz S) Am J Cancer Res 2017;7(12):2587-2599 PMID: 29312811 PMCID: PMC5752698 01/10/2018    
  • Minimally invasive hepatectomy conversions: an analysis of risk factors and outcomes. (Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Clark Gamblin T) HPB (Oxford) 2018 02;20(2):132-139 PMID: 29183702 12/01/2017    
  • Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base. (Berger NG, Silva JP, Mogal H, Clarke CN, Bedi M, Charlson J, Christians KK, Tsai S, Gamblin TC) Surgery 2018 02;163(2):318-323 PMID: 28943041 09/26/2017       3 Citations
  • Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival. (Clarke CN, Lee MS, Wei W, Manyam G, Jiang ZQ, Lu Y, Morris J, Broom B, Menter D, Vilar-Sanchez E, Raghav K, Eng C, Chang GJ, Simon I, Bernards R, Overman M, Mills GB, Maru D, Kopetz S) Ann Surg Oncol 2017 Dec;24(13):4051-4058 PMID: 28936799 PMCID: PMC6063735 09/25/2017    
  • Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy? (Barnes CA, Krepline AN, Aldakkak M, Clarke CN, Christians KK, Khan AH, Hunt BC, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S) J Gastrointest Surg 2017 Nov;21(11):1793-1803 PMID: 28849366 08/30/2017       2 Citations
  • The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients. (Silva JP, Gorman RA, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC) J Surg Oncol 2017 Dec;116(7):831-840 PMID: 28743160 07/26/2017       4 Citations
  • Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. (Silva JP, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, White S, Rilling W, Gamblin TC) HPB (Oxford) 2017 08;19(8):659-666 PMID: 28552299 05/30/2017       9 Citations
  • Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. (Clarke CN, Choi H, Hou P, Davis CH, Ma J, Rashid A, Vauthey JN, Aloia TA) HPB (Oxford) 2017 08;19(8):706-712 PMID: 28528267 05/22/2017    
  • External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database. (Berger NG, Tanious MN, Hammad AY, Miura JT, Mogal H, Clarke CN, Christians KK, Tsai S, Gamblin TC) J Surg Oncol 2017 Sep;116(3):307-312 PMID: 28464313 05/04/2017       1 Citations
  • Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma. (Silva-Figueroa AM, Hess KR, Williams MD, Clarke CN, Christakis I, Graham PH, Grubbs EG, Lee JE, Busaidy NL, Perrier ND) J Am Coll Surg 2017 Mar 15 PMID: 28427885 04/22/2017    
  • Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases. (Yamashita S, Brudvik KW, Kopetz SE, Maru D, Clarke CN, Passot G, Conrad C, Chun YS, Aloia TA, Vauthey JN) Ann Surg 2018 03;267(3):514-520 PMID: 28002060 PMCID: PMC5901745 12/22/2016       12 Citations
  • Implementation of a standardized electronic tool improves compliance, accuracy, and efficiency of trainee-to-trainee patient care handoffs after complex general surgical oncology procedures. (Clarke CN, Patel SH, Day RW, George S, Sweeney C, Monetes De Oca GA, Aiss MA, Grubbs EG, Bednarski BK, Lee JE, Bodurka DC, Skibber JM, Aloia TA) Surgery 2017 03;161(3):869-875 PMID: 27825699 11/09/2016       1 Citations
  • Oncologic progress for the treatment of parathyroid carcinoma is needed. (Christakis I, Silva AM, Kwatampora LJ, Warneke CL, Clarke CN, Williams MD, Grubbs EG, Lee JE, Busaidy NL, Perrier ND) J Surg Oncol 2016 Nov;114(6):708-713 PMID: 27753088 10/30/2016       8 Citations
  • Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature. (Christakis I, Busaidy NL, Cote GJ, Williams MD, Hyde SM, Silva Figueroa AM, Kwatampora LJ, Clarke CN, Qiu W, Lee JE, Perrier ND) Int J Surg 2016 Jul;31:10-6 PMID: 27212590 05/24/2016       14 Citations
  • BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies. (Clarke CN, Kopetz ES) J Gastrointest Oncol 2015 Dec;6(6):660-7 PMID: 26697199 PMCID: PMC4671844 12/24/2015    
  • Factors affecting readmission after pancreaticoduodenectomy. (Clarke CN, Sussman JJ, Abbott DE, Ahmad SA) Adv Surg 2013;47:99-110 PMID: 24298846 12/05/2013       8 Citations
  • The effect of hepatic ischemia reperfusion injury in a murine model of nonalcoholic steatohepatitis. (Tevar AD, Clarke CN, Schuster R, Wang J, Edwards MJ, Lentsch AB) J Surg Res 2011 Jul;169(1):e7-14 PMID: 21492876 PMCID: PMC4599341 04/16/2011       5 Citations
  • Hypobaric hypoxia exacerbates the neuroinflammatory response to traumatic brain injury. (Goodman MD, Makley AT, Huber NL, Clarke CN, Friend LA, Schuster RM, Bailey SR, Barnes SL, Dorlac WC, Johannigman JA, Lentsch AB, Pritts TA) J Surg Res 2011 Jan;165(1):30-7 PMID: 20850781 PMCID: PMC4607063 09/21/2010       27 Citations
  • Portal vein ligation accelerates tumor growth in ligated, but not contralateral lobes. (Sakai N, Clarke CN, Schuster R, Blanchard J, Tevar AD, Edwards MJ, Lentsch AB) World J Gastroenterol 2010 Aug 14;16(30):3816-26 PMID: 20698045 PMCID: PMC2921094 08/11/2010       10 Citations
  • CXC chemokines play a critical role in liver injury, recovery, and regeneration. (Clarke CN, Kuboki S, Tevar A, Lentsch AB, Edwards M) Am J Surg 2009 Sep;198(3):415-9 PMID: 19716886 PMCID: PMC2736150 09/01/2009       37 Citations
  • Equine-related injury: a retrospective analysis of outcomes over a 10-year period. (Clarke CN, Tsuei BJ, Butler KL) Am J Surg 2008 May;195(5):702-4 PMID: 18424291 04/22/2008       17 Citations
  • Changing the substrate specificity of creatine kinase from creatine to glycocyamine: evidence for a highly evolved active site. (Jourden MJ, Clarke CN, Palmer AK, Barth EJ, Prada RC, Hale RN, Fraga D, Snider MJ, Edmiston PL) Biochim Biophys Acta 2007 Dec;1774(12):1519-27 PMID: 17976392 11/03/2007       10 Citations
  • Last update: 11/03/2018
    jenkins-FCD Prod-300 626508253d14e4184314fb9f66322a03a5906796